SOM Biotech at BIO 2019

posted on June 13, 2019
SOM Biotech attended the BIO International Convention in Philadelphia last 3-6 June 2019. BIO is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on major trends affecting the industry. This year 4.075 companies attended with more than…
continue reading →

SOM Biotech at the International Congress 2019 on Duchenne Muscular Dystrophy and Becker

posted on June 13, 2019
Dr. Raúl Insa, SOM Biotech CEO, gave a talk on the topic "Repositioning of Utrophin" at the International Congress 2019 on Duchenne Muscular Dystrophy and Becker, an event organized by Duchenne Parent Project España. The Congress took place in Madrid from 7th to 9th of June. The Congress analyzed the different therapeutic strategies that exist…
continue reading →

Interview of SOM Biotech for Labiotech.eu

posted on May 8, 2019
Dr. Raúl Insa, SOM Biotech CEO, gave an interview to Labiotech.eu, leading digital media covering the European Biotech industry, read by 100000+ monthly visitors. In this interview, Dr. Insa explained the mission of SOM Biotech, advantages of drug repurposing and aspects of drug development for Orphan diseases. SOM Biotech’s CEO also talked about the current…
continue reading →

SOM Biotech will attend the 12th Annual Global Discovery to Development Innovation Forum (GDDIF)

posted on May 8, 2019
Dr. Luca Signorile, Senior computational chemist at SOM Biotech, will be attending the 12th Annual Global Discovery to Development Innovation Forum (GDDIF) that will take place in Amsterdam on 14th – 15th of May. The Annual GDDIF is the leading pharmaceutical Research & Development summit for pharma decision makers, scientific leaders, and solutions experts. Taking a…
continue reading →

SOM Biotech at TechShare – pre-IPO programme launched by Euronext

posted on May 8, 2019
Dr. Raúl Insa, SOM Biotech CEO, attended the second campus of the 2018-2019 TechShare programme organized by Euronext and Nova School of Business and Economics (Nova SBE). The event took place on 15th and 16th of March in Lisbon, Portugal. TechShare is an educational and mentoring programme which aims to familiarize the CEOs of Bio-Tech companies with the financial markets.…
continue reading →

3rd Annual Clinical Trials Summit (CTS) 2019

posted on April 27, 2019
Dr. Santiago Esteva, Head of Clinical Operations at SOM Biotech, will be presenting at the 3rd Annual Clinical Trials Summit that will take place in Barcelona next April 29 and 30. He will be discussing about the relationship of small biotech companies and CROs from SOM’s perspective, highlighting the challenges in selecting a CRO to conduct the…
continue reading →